TY - JOUR
T1 - Home parenteral nutrition for advanced cancer patients
T2 - Contributes to survival?
AU - Theilla, Miriam
AU - Cohen, Johnathan
AU - Kagan, Ilya
AU - Attal-Singer, Joelle
AU - Lev, Shaul
AU - Singer, Pierre
N1 - Publisher Copyright:
© 2017 Elsevier Inc.
PY - 2018/10
Y1 - 2018/10
N2 - Objectives: Patients with advanced cancer often suffer from severe malnutrition and gastrointestinal obstruction. This population could benefit from home parenteral nutrition (HPN). The aim of this study was to observe the outcome of patients with advanced cancer patients who were eligible for HPN. Methods: All patients in the nutrition clinic who received HPN over the past 7 y were included in the present study. We compared patients with advanced cancer with the noncancer population in terms of hospitalization rate and mortality. Results: Of 221 advanced cancer patients, 153 who had no oral/enteral intake and who received HPN survived. Of these, 35% survived for 6 mo, 27% for 1 y, 18.9% survived 2 y, and 3.9% survived for the 7 y of the follow-up. Hospitalization rate was not significantly different from the noncancer population. Conclusion: These results show that HPN is a relevant palliative therapy for patients with advanced cancer patients without oral or enteral feeding access.
AB - Objectives: Patients with advanced cancer often suffer from severe malnutrition and gastrointestinal obstruction. This population could benefit from home parenteral nutrition (HPN). The aim of this study was to observe the outcome of patients with advanced cancer patients who were eligible for HPN. Methods: All patients in the nutrition clinic who received HPN over the past 7 y were included in the present study. We compared patients with advanced cancer with the noncancer population in terms of hospitalization rate and mortality. Results: Of 221 advanced cancer patients, 153 who had no oral/enteral intake and who received HPN survived. Of these, 35% survived for 6 mo, 27% for 1 y, 18.9% survived 2 y, and 3.9% survived for the 7 y of the follow-up. Hospitalization rate was not significantly different from the noncancer population. Conclusion: These results show that HPN is a relevant palliative therapy for patients with advanced cancer patients without oral or enteral feeding access.
KW - Advanced cancer
KW - Gastrointestinal obstruction
KW - Home parenteral nutrition
KW - Karnofsky scale score
KW - Palliative care
UR - http://www.scopus.com/inward/record.url?scp=85019720769&partnerID=8YFLogxK
U2 - 10.1016/j.nut.2017.03.005
DO - 10.1016/j.nut.2017.03.005
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 28571682
AN - SCOPUS:85019720769
SN - 0899-9007
VL - 54
SP - 197
EP - 200
JO - Nutrition
JF - Nutrition
ER -
